canakinumab
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including ... ,Canakinumab is an interleukin-1β (IL-1β) blocker, which works to suppress the production of an inflammatory protein. Increased levels of IL-1β cause ...
| 相關軟體 Canvas X 資訊 | |
|---|---|
 canakinumab 相關參考資料
Autoinflammatory Disease Treatment | ILARIS® ...
ILARIS can cause serious side effects, including increased risk of serious infections. ILARIS can lower the ability of your immune system to fight infections. https://www.ilaris.com Canakinumab
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including ... https://en.wikipedia.org Canakinumab (Ilaris)
Canakinumab is an interleukin-1β (IL-1β) blocker, which works to suppress the production of an inflammatory protein. Increased levels of IL-1β cause ... https://rheumatology.org Canakinumab (Subcutaneous Route)
Canakinumab injection is used to treat cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells ... https://www.mayoclinic.org Canakinumab - an overview | ScienceDirect Topics
Canakinumab is a human monoclonal antibody that selectively targets interleukin-1β. It has no cross-reactivity with other members of the interleukin-1 family, ... https://www.sciencedirect.com Canakinumab - PMC
由 E Dhimolea 著作 · 2010 · 被引用 245 次 — Canakinumab is a human IgGκ monoclonal antibody targeting IL-1β that was developed by Novartis for the treatment of immune disorders. The drug was granted ..... https://www.ncbi.nlm.nih.gov Canakinumab: Uses, Interactions, Mechanism of Action
Canakinumab is an interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial ... https://go.drugbank.com Ilaris (canakinumab) dosing, indications, interactions, ...
Canakinumab may help to lessen the symptoms, such as rash, joint/muscle pain, fever, eye redness, and tiredness.Canakinumab is also used to treat gout attacks ( ... https://reference.medscape.com Ilaris, INN-canakinumab
Canakinumab should be used as an on-demand therapy to treat gouty arthritis attacks. The recommended dose of canakinumab for adult patients with gouty arthritis ... https://www.ema.europa.eu |